CA1296663C - Arabinonucleic acid probes for dna/rna assays - Google Patents

Arabinonucleic acid probes for dna/rna assays

Info

Publication number
CA1296663C
CA1296663C CA000525772A CA525772A CA1296663C CA 1296663 C CA1296663 C CA 1296663C CA 000525772 A CA000525772 A CA 000525772A CA 525772 A CA525772 A CA 525772A CA 1296663 C CA1296663 C CA 1296663C
Authority
CA
Canada
Prior art keywords
probe
dna
acid
arabinonucleic
label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000525772A
Other languages
French (fr)
Inventor
Randy Miles Mccormick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PerkinElmer Health Sciences Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Application granted granted Critical
Publication of CA1296663C publication Critical patent/CA1296663C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens

Abstract

ARABINOUNUCLEIC ACID PROBES FOR DNA/RNA ASSAYS
ABSTRACT
A novel nucleic acid, arabinonucleic acid, is provided as a probe in nucleic acid assays. The anti-arabinose antibody-label conjugates.

Description

2~6~6~

TITLE IP-05~9 TECHNICAL FI~LD
Thi6 inYention i~ rela~ed ~o arabinonueleic acid and the u6e of thi~ novel ~olynucleot~de pzobe l~
~NA or RNA hybrid~zaeion a6~ay6 ~nd e6pecially ~o probe~ con~aining a binding 6ite in every ~on6t~tuent nucleotide. Thi~ per~it6 the at~achment of ~ ~etection ~oiety to each nucleot$de of ~he probe and ~hu6 leads ~O ~mproved deeectlon sensitlvi~y.

BACKGROUND ART
Hybridization probe6 u6e~ in DNA an~ ~N~
as~ay6 are labeled i~ ~ome fa6~io~ ~o ~cili~at~
detection o~ the duple~ aft~r the probe ha~ hybri~ized with a complementary ~trand o~ ~ar~e~ DNA or ~N~ ln the ~ample under ~nalyBi6~ Mo~t ~ommonly, the probe can be label~d by enzy~atically in~orporating r~dio-labeled ~ucleotide~ on ~he 3' or 5' ter~inu6 o~ the probe. tA.~. Maxam et al., Me~hO Enzy~ol. Volu~e 65, 499-560 (19~0)~. AlternatiYely~ higher level~ o~
radiolabeled nucleotides can ~e in~o~porat~ by ~
tran61ation tP.~.J. ~gby ~t al., J. ~ol. ~lol. Yolu~e 113, 237-251 (1977)1. Thi~ er ~hod ~o~e~e~
the inh~r~nt advantage o~ b~in~ abl~ to ~ncocp~x~te one radioactiv0 ~ho6phoru~ per ~on~ti~uen~ ~ucleotide ln the probe and ~hu6 as~ay~ u6in~ the6e probe~ ~re ~harac~0rizsd by the ~06t ~n~i~iv~ de~tion lioit~
in hybridization a~say~. The obviou6 di62dv~a~e~ of the~e prob~g are the hazard~ and inconv~nien~
associat~ wi~h the u6a o~ radioiso~op~6.
A ~e~ond type of label in~olv~ 0nzy~atl~11y 6ynthe6izing ~ probe with a ~$x~ure o nucl~otide~
containing a biotinylated pyri~idine ba6e (ur~cil or ~d~no~ine) incorpo~ated in~o one o~ ehe nu~Ieo~idQ6 ~ .

te.g., P. ~. Langer ~t al., Pcoc. ~atl. AGad. &c~ 5A
Volu~e 7~, 6633-~37 (1~81)~. Alternati~rely, biotin-ylated hi6tone Hl protein6 can be chemically cro~-lirlked with ba6es in DNA to yiela ~ 13bele~ probe S lM. P~e~z, E~SB0 J. Volums 2(i), 017-822 (1983~1. Ater hybridization of the probe ~o a complementary ~trana o~ target DNA. the hyb~id ~i~ trea~ed with a ~epo~ter molecule attached to aYidirl which bind~ tenaciou~ly ~o the ~otin moiet~e6 ~a ~he pro~e. ~he repor~er can be 1~ eitbe- all opaque poly~eric ~D~cro6phere bound ~o av~din ~0. C. Richard6 et ~1., Proe. Natl. Acad. ~c~. USA
Volu~e 76(2), 676-680 (1979~] or avidl~-~erriti~
t~- Sod~a ~t ~1., Nucl. P.ela6 P~e~. Volu~e 5(2),, 3~5-~01 ~197~) ] . Each o~ ~he~e can ~e vi6ualized ~
15 ~lectron ~sro6copy. Alte~nat~v~ly, the ~eport~r ~ay be an avidin-enzyrae complex which whe~ treatea w~th the er~zy~e ' 6 ~ub6tr~te, will yield a ~rieually t~t8C~-able colored product tJ. J. Leary et ~1., Proc. Natl.
Acad. Sci. USA. Volume 80 4045-4049 (1983)]. Afi6ay6 20 based on these probe~ obviate l;he Ul;9 of radioactiYe ateri~16: howe-ver, only About 2~ o~ nuclooti~e6 in ~ given probe ~Role~ule can be deri~rat4zed ~ith a biotin ~oi~ty withou~ reducing the specif icity o~ the probe for it~ comple~Qnta~y s~ran~ of sa~pl~ DNA. Thi$
25 reduction in ~peciîici~y ari~6 fro~ ~odific~ion o~
~che 2bili~y o$ comple~e~lt~ry bags~ to ~ir prop~rly because og the pr~sence of the blot~n aoiQty~ The reduced 4ncorporation of l~bel in the~e ~robe~
relativ0 to ra~ioactive probes ro~ul~ in ~ ~oorer 30 detection 6en6il~ivity,.
A third ty~e o~ label ~5 ~n ~nzy~e directly ~ttached ~o the ~robe ~uch tha~ ~te~ b.ybri~i2ation the enzylDe in the hybrid ~ ~ ~reated with ~ub~trate to yield a colored product. The ~nzy~ne can ~e bonaed 3s directly to ba6e& in the probe tP~. ~enæ ~t al., Nucl.

~.;29~

Ac~d6 ae6., Volume 12(8), 3435-3444 (1g8~J or ~o ba~es in another ~trand of DNA ~omplementa~y ~o 2 leng~h of oligonucleotide c~em~cally attached tb tbe ~nd of the probe tJ. G. Woodhea~ et ~l~o Biochem. Soc., Trang., 5 ~olu~e 12(2), 279-~o ~1984)]. I~ the ~tt0L ~a8e, th~ ~robe 16 hybridized to complementary tar~et DNA
and thi~ hybri~ ~ treated wi~h the ol~gonucleot~de containing the enzyme label6. Thi6 ~trand o labeled oligonucleotide binæs with ~he single-~randed tall o~
10 ~omplementary DNA which had bee~ chemically attached eo the ena of ~he probe. Visualizatio~ o~ the ~nzy~e reporter6 t6 accomplished by ~onver~io~ of the enzyme'6 ~ubstrate to colored p~oduct. The pri~ary ~iffi~ultie6 a6~0ciated with ~hi6 proceau~e ari6~ from the low level of enzyme attachm~nt and the lo~ o enzy~e activa~y when ~ubjected ~o t~e ~t~ingent condition~
(eOg. elevated temperatur~, nonaqueous ~ol~ent) ~ypi-cally u6ed i~ the hybridizætion pro~ocol. A ~econdary dificulty a660ciated with the la~er o~ the~e labeling ~ethod6 i6 the po66ibility ~hat the 6ynt~etic 6tr~nd of oligonucle~tide containi~g the ~nzyme l~bel ~ight be comple~ent~ry to a 6e~uence o naturally-occurring nucleo~ide6 in the ~ample. Thus, i~ additlon to pairing wi~h the ~eque~c~ o~ b~e~ ~ttached ~o th2 end of the hybri~izatlon probe, the enzyme-lab~led oligonucleoti~e ~y bind non~pe~ically to natur~l ~equence~ of comple~ntary ba~es a~ld thus l~d to backgroun~ problem6 i~ ~ample~ u6ed a~ ~eg~tive controlfi or bl~nk~.
A ~ourth typ~ o lab~l in~olve~ coupling a ~luorophore either to b~ e6 ~n the con~tituen~ nu~leo-tid~ of ~he pro~e IC. H. Yang ~t a~ . B~oche~.
Volume 13. 3615-3~20 (1974)3 or to ~be 3'-~@r~inu6 ~R. ~. ai~hard60n et al.~ Nucl. A~ Re6. Volu~e 11(8), 6167-6184 (1983)] or to the 5I ter~inus 6~6~

~C. H. Yang et al., Arch. Bioche~. Biophye., Volu~e 155, 70~ 973~1 of ehe probe. As above, the ~en~i-~vi~y o~ the6e method6 ~6 limit~d by the ~all number of label~ whic~ can be incorporat~d into ~ach copy o~
5 the probe.
A fifth type of label involYe~ ~he use of a~
ant~body directea against 60me ~ntigenlc deter~ina~
in the probe or in t~e targe~-probe duplex. I~ the ~ormer ea8e. an antigenic determ~n~nt (e.~., bioti~, lQ bro~ine, ~-aceto~y-N 2-acetylamino~luorene) ~
covalen~ly coupled to ba6e6 i~ t~e ~u~leoeide ~, ~he probe te.g., L. Manuelidi~ o~ al., J. Cell ~iol.
Volume 95, 617-625 ~1982)]. ~he6e antigenig ~et~r-~inants ~ay iDterfere ~it~ speci~i~ hybr~dization a~d ~5 limit ~he util~ty of t~e probe. In the lat~er ca~, ehe double-6tranded DNA-RNA hybrl~ itsel~ lfi i~uno-logi~ally dis~ingui~able ro~ DNA-DNA and RN~-~NA
duplexe6 ~G. ~. Rudki~ et al.~ Nature, Volume 265.
472-~73 (1977)~. The ant~genic de~erminant ia the probe-target duplex was detected with an a~tlbody-fluorophore con~ugate ~nd fluor~6cenc~ ~icro~aopy.
The lab~led probe can ~l~o ~ dete~ted with antibodie6 to which ~n en~yme ~L. Manu~lidi~ o~ ~1., op~ ) 0 ~olloidal ~ol~ tN. J. ~utchi~on et al., J. Csll ~$ol./
Volume 95, 609-618 tl982)] has b~e~ ce~ugat~d. A~ai~, the ultimate senEiti~lty i~ ited by the nu~r of abelB av~ilabla to detect a hybridizatio~ o~e~t.
~ he infi~ant invention ove~co~e6 ~he limit~tis~
of th~ prior ~r~ ~y incorpor~ti~g ~he ~axi~al ~u~bQr o2 nonradioactlve la~el~. o~e per nucleoti~e, ~nt9 ea~h probe wit~ negllg~ble e~f~ct on hybriaiz~io~
~fficien~y or 6pe~ifi~ty.

6~i3 DI SCLOSUR~: OF TH~ I~VENTION
Thi6 invent~on involve6 a new nucleic acid, arabinonucleic a~id.
The me~t~oa of thi6 inv~ntion for iderltifying rlucleic acid 6equences s:omprise6 the B~ep~ o~:
(a) rendering the ta~get ~u~leic aci~
6ingle-~tranded:
(~ immobll~z~ng ~he 6i~agle-st~an~ed nucl~ic acid6 onto a 6upport:
10 ~c) allowing 6aia single-6trandea r~ucleic acid6 to hybrldize with i 6ingle-~tranded arabinonucle~ ~cid probe:
) wa6hing 6aid 6UppO1~ ~0 r~mo~ ~rabil~o-~ucleic acid not incorporated ~n~o 'clhe ~yb~ ormed oal the 8uppo~t: ~a ~e) determin~ng l:he pre~enGe of arabinonu-elei~ acid i~ the hybrid orDIea o~ tbe 6upport by conta~ting i~ ant~-arabino~e antibody-label conjugate ~nd detecting ~aid la~el.

DE S CR 1 PT 1 ON OF THE I NV~NT I O~N
Thi6 inv~antio~ volve6 th~ ~yn~hesi~ ~d u6e o~ ~ novel hybridization prob~ ~or DNA ~nd RNA ~ y~.
25 Thi6 new probe. arabinonucleic aci~ (ANA), IIAB ~n arabino~e sUgar rQ~l~cing ~he sor~v~ion~l ~ibo6e or deoxyribo~e 6ugar~ found i~ RNA arld ~dA, re~p~c~iv~ly.
~hi~ uncommon cugar provi~e~ b~ ling ~ito~ ~or ~ anti-arablno~e ~ntibody-label which ca~ b~ us~a to aetect 30 seleetively ~he ar~bino6~ sugar ana thu6 any ~robe containing the s~ugar. Th~ ~u~ar arabinos~ 1~ susl~
only ~n th~6 syntheti~ p~o~e and ~o~ ~n ~ y ~atur~lly-oocllrring DNA or RNA~ ~nd. tberefore, the dete~ion ~ntibody will bind only eo the ~rabino6e ~11Oiet~:26 ~t~
35 the probe.

, , . , , ..

, : ' , ~ ., ~ he probe can be 6ynthesized either ~hemically or enzymatically. Chemic~l 6ynthesis involves the ~ntroduction of protective group6 on the 2', 3' and 5 carbon a~o~6 of the arabino6~ ~ugar ~n ~ ~uGleosi~e 5 ~ontainiDg arabino6e in6~ea~ o~ ribo6e or deoxyrl-bo6e. Such nucleo~ide~ are commer~ially available.
The chemical nature and ~e~hod of a~tachi~ the pro~ectiYe group~ ha~ been develope~ ~or ribonucleo-6ide6 and de~xyrlbonucleo6ide~ tG. ~. Hakimeliah ~t 10 al.~ Can. J. Chem., Volume 60, 1106-1113 (1982)J and can be adap~ed for ~rotec~lon o~ the corre6pond~ng po6itlon6 in arab~nonu~leo~lae~ 1~. K. Og~lvi~ ~ al., Can. J. Chem., Volu~e 61, ~204-1212 ~19~3)~. O~ce the pro~ec~on of the ara~nonucl~o6~qe~ has ~een achievea, the chemical fiynthesi~ o~ t~e arabinonucleic acia probe c~n then p~o~eea in the ~annar u~ed fo~ DNA ana RNA probe6. in that the ~orrec~ nu~l~o~ide6 wlll be 6eguentially lin~ed to form ~ chai~ of nu~leotide~
which 1~ co~ple~entary ~o a ~equence of nucleotide~ in zo tar~et DNA or RNA in the ~ampl~ under analy~i~ (M. H.
Caruther~ et al., ~n Gen~tic ~nsi~2eri~g, ~. Setlo~, : ed.~ Vol. 4~ 1-17, 1982).
Nucle~ a~i~B to b~ analyzsd ha~e ~a~y ~ource~. These incluae ~lin~c~l ~peci~en6, ~ariou~
~icroorgani~ such as b~cter~a~ viruse~, ~hl~mydia, rickett6ia, ~ycopla~ma ~nd protozoa. plants, ~ong other~. Extraction 1~ one common ~ethod Pol collectin~
the nucleic ~cid~ fro~ the~r ~ourc~ ~or hybr~iza~lon ~66ays. The ~oto~ol for use of ~h2 ~NA probe~ o~ thi~
inventio~ i6 ~uch like that ~n ~onventtonal hybriaiza-tion proce~u~e~. The taLget DNA or RNA i~ ~ir~ ren-dered 6ingle-~rand0d and th~n i~mobiliz~ o~to ~
~uppor:t. The i~obilizea single-6tranded nucle~c ac~d6 ~re ~hen treated~wi~ the arabinonucleic a~id ~: 35 probe complementary to ~e~uence of ba~e6 in the ~, ` ~
~Z96G6;3 target. Hybridization of ~he arabinonucleic ~c~
probe with the complementary 8equence of bases ~
allowed to occur. Ater washing to semove exce36 unhybridized ANA probe. the probe-target hybr~
treated with an anti-arabino6e antibody-label ~on~u-qate.
The antibody it~elf i~ raified against ~he C2 chiral ~ite in arabino6e or t~e C2 ~ite in con~unct~o~
wi~h other antigenic determinant~ in the a~a~ino8e or 1~ ~NA 6tructures tOkabaya~hi e~ ~1., Cancer Re~earc~
Volu~e 37, 61g-624 [1977)1. The antibody-co~ugate can be prepared by con~entional ~ean6. The label ~an be enzymat~c~ fluorescent, ch~milu~ine6cent or ~acro-molecular, the preferEea one being ~nzymatie.
Thi~ antibody-la~el con~ugate 6pecif~c~11y bind6 to t~e arabino~e ~ugar but not ts ribo6e or deoxyribo6e pre6ent in native %NA or DNA. After treat~en~ 6uch as wa~hing to remove exces6. unbound antibody-enzyme conjugate ~rom the ~y6te~ it ~
2~ treated with ~he enzyme ' 6 6ub6trate ~o produce a detectable ~ignal such a6 a colored product, indi--~ating the pre6ence of tha targe~ nucleic aci~ i~
the ~ample. Labels other ~han enzyme6 ca~, of cour~e, be detected app~op~ Qly.
Altsrnat~v~ly, one can envi6io~ othor ~indi~
r~agent6, euch a6 a l~ctin, which could be oon5u~a~d eo an enzyme or oth~r lab~ls. The a~say protocol for ~uch ~ con~ugate would be similar eo that ~ove, ~rabinonucleic acid probe6 hav~ ~e~eral unique aavantag26. Since one arabino~e bin~ing ~t~
~an be incorporated inSo ~ach nucleotide of tb~
hybridization probe, each nucleoti~e ~6 capa~le of hav~ng an anti-arabino6e antibody-label bouna to lt to achieve labeling at the 12vel6 usually ob~ainable with radioi~otope~. At the ~a~e ti~e, the ~azara~ o~ ra~io-;
, i6~
a ac~ive material6 are avoi~ed. I~ addition, the6e fullyla~eled probe6 will not un~ergo the ~egradation that radiolabeled probeL experien~e due to 1YBi~ by the h~gh-energy decay product~ of the radiolabels. Further-~ore, since detectability o~ the AN~ relies upo~ ~heinverted chirality aboue thQ C2 carbon atom in the sugar backbone of the probe, ~nd ~ince th~ che~cal bond6 about the C2 earbon a~om ~re ~ot involved ~
determining ei~her ~he intra- or ~nter-~trand Etructure of the probe or the probe-tar~et hybrld, specifici~y of ~he probe and the stabili~y o~ the probe-target hybr~d are not expec~ed to be ~ffe~tea ~ignific~tly. This higher degree of labeli~g o ~he ~NA probe. achieved without altering t~e 6pecificity o~ the probe ~or i~6 complementary ~eguence of ba~e6, ~ak~ the probe6 of thi6 invention ~uperior to ~he ~he~i~ally aerivatized probe~ sf the prior art. Finally, the arabino6e in the probe can be speci~ically det~c~ea u6ing ~n antibody-enzyme ~on3ugate. The advantage o~ the use of an enzyme label derive~ from th~ high ~gree o 6ignal magnification due eo ~he large t~r~over o~
~ub~trate to produ~t. ~hUfi, U8~ 0~ antibody-enzy~e con~u~at2s to ~e~ect ~rabino~e po66e6ee6 ~ot only the advant~ge o~ the high ~egr~e o~ pro~e labeli~g characteristic of rAdiolabel~d probe~ but al30 ~he ~ign~l maqnif ication o~ an enzyme-ba3ed nonradio~r~
a6~a~.

B

. .

~Z~6~3 Exampl~_~
. Chemical SYnthe61~_of Protected Arabinonucleoti~es for Probe Synthesl6 Probe 6ynthe~i6 through chem~cal polymeriza-5 tion o nucleotide6 cequi~e the avail~bility of ~tlea6t four protected and activated arabinonucl~oti containing the ba6e6 guanin~, cy~o6ine, adenine, ana ura~il or thy~ine. Each o~ the6e protectea nucleo-tide6 can be prepared from the ~orre~ponding nucleo-~de~, whiCh are commercially availabl~.
~ he addition of protective ~nd activatinggroup6 ~v a nucleo~ide will be ~11UBtrated ~or the preparation of the protec~ed and activated nucleo~ide arab~nouracil tarav). The other ara~inonucleo~iaes were protected and activ~tea ~n 9~ i~entical ~a~ner:
in add~t~o~. nu~leo6ide~ ~ont~iniag the ba~e~ eyto6i~e and adenine ~equired proteetion o~ the base ~t6el~ ~n t~e form of ~ benzoyl group while guani~e ~equired D~
i~obutyryl pro~ecting group.
Fir6t. a di~ethoxytrityl (D~T) group wa6 introauced at tbe hydroxyl on the 5'-~arbo~ o~
arabinose. ~hi~ wa~ done by addi~g 7.75 ~mo~ of dimethoxytrltyl chloride (DMTCl) i~ ~igh~ equal por~
tion6 at l-hour ~nterval6 to 6.5 m~ol~ o~ ~-D ~rabino-uracil di~aolved in 30 m~ pyri~ine ~t -5~C. On~ hour a~t~r the ~inal ~ddition. the reactio~ ~ixtur~ wa~
pour~d into ice wat~r to de~troy exc~ di~etboxy-trityl chloride and re~ucea to ~ ~um ~ ~pproximat~ly 250C on a roeary ~vaporator. The product, 5'-D~T
~raU, wag i601at~a fro~ t~e r~action ~ixture o~ a eolu~n o~ Mer~k Xie~elg~l ~0 ~ a g~l elutQa with g5/5 ~ixture of ~hlorofor~ethan~ ld~ o~ 90-~5 ~ere obtained.
A;ter~-butyldi~ethy~ilyl 9lOUp (TBD~) wa~
~hen introduced 2t th~ hydroxyl ~roup OA th~ carbon : 9 '~....

6~

of ~rabino~e ~n ~he ardb~nonucleo6i~. 5'-DM~ ~ra~, 5.5 Dmole6, prepareA ~6 ~boYe, W3B ~i6601ve~ ~n ~e-thoxyethane (1~0 ~L) ~nd ~4 ~mole6 of tr~ethyl~ne ~a6 ~ded. Next. 16.5 ~mole6 o~ ~lver n~trat~ ~a6 added an~ the mixture ~tirr~ for 1 h~ur ~t roo~
temperature. Then, 16.5 mmole6 of t~rt-bu~yl-di~ethyl611yl ~hlor~e wa6 ~d~ed and ~h~ r~actio~
~ixture sti~red or 5 hour~ a~ Eoom temperature.
~e reactio~ ~xture wa6 f~ltered into ~ 10% ~olut~o~
of ~odiu~ bicarbonate ~nd tbe ~queou6 ~ixture wa~
extr&~e~ twice ~it~ ~ethylene ehlori~@. The org~nic ~xtrac~ wa6 evapor~ed to dryne~6 ~n~ 5'-DMT~3'-TBDMS
~raU wa6 1601~tea i~ 75~ yiel~ fro~ a ~ex~k Kie~elge~
60 6ilica gel cQlu~n elutea w~t~ yl ~e~ate.
A ~enzoyl (Bz) ~rotecti~ group w~ introdu~ed at the hydroYyl on t~e 2'-earbo~ ~P ~rabino6e i~ the nucle~6ide by ~16~olving 5.~ ~m~1~6 0~ the previou~ly preparea ~ MT,3~-TBDMS araU in ~9 ~L of pyridine and cooling ~o -~5C. An ex~e6s (6.6 mmol~ç) o~ benzoyl chloride in methylene chloriae wa6 ~daea dropwi~e to the ~t~rrea ~action ~ixture ~hi~h ~as beld at -~S-C
for ~0 ~inute6 after addi~ion W~6 co~plot~. The ~c-eio~ ~ixture W~6 wa~ed ~n~ h01~ ~t -20-C ~or 2 ~our~.
~fter addit~on o~ ~t2r ~o ~ydrolyz~ unre~cta~ be~zoyl chlori~e, the ~xture was r~duc~A ~o a ~u~ o~ ~ rot~ry evapor~tor and 5~-DM~. 3 ' -TBDMS, 2 ' -Bz a~U w~ olat~d on a ~lic~ ~ol ~olu~n ~lut~ w~t~ ~ 50/50 ~x~ure o~
toluene ~nd ~thyl ~cet~te.
The te~porary block~n~ ~roup (TsDM~) on ~he hydroxyl on t~o 3~arbo~ va~ r~mov~ by gro~ting 0. 7a ~molo o~ 5~-DMr~3~-TBDMs~2~-~z ~r~V w~e~ 2.5 D~ol~ of lM ~etrabutylam~on~u~ 1uor~e (~ TH~ ~t 25-C ~o~
0.5 bour. ~e 5'-DM~,2'-~2 ~raV ~a~ ~ola~ rOD
~i~ica gel column eluted with ethyl ~c~t~.

* denotes trade mark ~0 ~z~66~

1~
~ h0 ~inal step in ~he prepara~ion of the nucleotide involved the acti~at1on of the hydroxyl group on t~e 3'-~arbon wi~h a pho6phine. 5'-DMT,~ z ar~ 77 ~mole6) wa~ di~601ved i~ ~Z3 ~ o ~ethylene 5 chloride containing 48 ~L ~ ~iisopr~pylethylami~e.
Nex~, 31 ~L o~ N,N-dii60propylmethylphosphonami~c chloride wa6 added Yia 6yr~nge ~o the s~irr~d ~eactio~
~ixture at 20~. After 15 ~inu~e~, the rea~tion ~
~ure wa~ diluted ~ith ethyl acetate and ex~racted with 1~ agueou6 60dium b~carbonate t~atura~ed). The o~gani~
~ayer wa~ 6eparated ~ro~ the ~qu~ou6 bi~arbonat~. dried with Na2504 a~d redu~ea on ~ ~otazy ~vapo~ator ~o y~eld the de6~ed actiYated and protected nucleo~i~e.

15 B. Pro~e Svnthe~i~
It i6 envi6ioned ~a~ ~ynthe6is of ~ oli~o-~eric ANA probe will follow the procedures ~eveloped for produc~ion o~ DNA probe u~i~g ~i~ila~ly pro~ected and acti~ated deoxynucleotides t~. H. Caruther~, 0~
z~ al~, in Genetic En~ineerinq, ~. Se~low, ~. Volu~e ~.
pp. 1-17). According to ~he6e ~roc~dure~, the t~r~t 6~p in the 6ynthe~i6 woul~ ~e th~ aadit~o~ o~ ~
~tarter ~erivatized arabino~ucl~o~ to a ~ nol-der~vattze~ Bilica support~ Thi~ wlll be ~oa~ by Z5 roactlng the appropriate 5'D~T,2'-~z ~rabinonuclQ
~ide ~ith ~uc~inic anhydrid~. The ~uccinyl~a arabinonucleo~i~e would b~ ~o~verte~ to the p-ni~ro-phenyl ester by reActlon with p-nit~ophenol ana ~y-clohexyl earbodiim~d~. Th~ ~G~iYated ~ucl~06id~ will be reacted wi~h a~inopropyl-deriv~iz~d ~ c~ g~
~ ixture ~ ethylfor~amide, d~ox~e, ~nd triethyl-a~ine. Unre~cted 6ilanol ~roup~ o~ the sil~c~ will be blocked ~y reaction wi~h acetic anhydride. The6e ~p~
~ould re6ult in the sil~ca gel having ~he nucleo6ide a~tached ~o it a~ tb~ 3' 2nd and, therefore, t~i6 ~1 ,, .,, ~, . . .. .
. -66~

nucleo6ide will be at the 3l-end of the probe to be ~ynthe6izea.
The next nucleotide can ~hen be added to the nucleo6ide attached to the ~ a suppo~t. ~he 8il~C~-nucleo6ide produ~t prepared above will be treat~ withp-toluene6ulfonic acid in acetonitril~ to re~ov~ ~he acid-labile dimethoxytr~tyl group from the hydloxyl group on the 5'~arbo~ atom of ghe nucleo6ide ~tached to the ~ilica ~upport. The nucl~o6ide on the ~upport 10 will be conden6ed wi~h the ~ppropriate arabinonucleo-tide phosphoramidite to ~dd th~ nex~ ~ucl~otido to the 5'-~nd of ~he growing probe. Thi~ rea~tion will be carr~ed out in the pre6ence of tetrazole i~ ary a~ets-~i~rile to ~acilitate tbe ~onden6atio~ rea~tion. The unrea~ted 5'-~yd~oxyl group of the arabinonucleo6i~e on ~h~ ~upport will b~ block~d by ~reatment, for 1-2 minute69 w~th a~e~ic anhydLide i~ di~ethyla~i~opyri-dine. The p~o6phite triester linkage fo~med by t~e preceding conden6ation will be oxidized to a pho6phate eçter by treatmen~ with a ~ixture o~ iodine and 2,6-~utidine in aqueoue eet~ahydro~uran ~or l-Z ~inu~6~
Thi~ ~t~p conclud~6 ~he addi~ion o~ a nucleoeid~ to the ~rowing ~robe, Additional nucleotiae6 caa be ~dded by repeating ~he ~bo~e ~action ~equence 3tarting w~th ~he removal o~ the protective group ~rom the 5'-hydroxyl in arabinose on the 5~-~nd o~ ~be probe.
Wh~ ~h~ ~ynth~ of th~ probe ~equs~e ~B
complete, the oligo~eric probe will ~Q tr~ated vi~h tri~thylamine and th$ophenol ~n ~oxane ~o convert the pho~phate trie0ters in ~ach nucleo~i~e l~nkag~ to pho6phate ~ie6ter~. The probe then vill b~ slaav~d from the 6ilica ~uppo~e by ereatment ~ith ~oncentra~ed ammoniu~ ~ydroxiae at 20C for 3 hour6. Thi6 trea~ment Will al60 re~ove the benzoyl protecting ~roup6 ~ro~
the 2~-hydroxyl group6 in each 3rabino6~ ~iety in ehe 61Ei3 probe and any protecting group6 ~r~m ~he ba6es. The oligomer~c ANA probe will be i601ated by rever~ea pha6e liquid chrorDatography and the ~lnal dimethoxyt~tyl group on the 5~-end o~ the pr~e ~ill be remov~a ~y 5 treatment w~th 20~ acet~c a~id to yield the purii~
ANA probe, which i8 ready for use in ~he hybridiza~ion as6ay .

C. HYbridi2ation P~ocedure It ~ envi~ion~d that the proto~ol ox u6e of ~NA pr~be~ would follow along th~ e6 of the ~ariou~
~ybridi~ation a~6ay~ eom~only util~z~ ~nd ~o li~
tion6 on the ~ub~titu~ion of ANA probe~ for DNA or aNA
probe6 in any sy6tem i~ o~eseen. In~tially, ehe tar-get or ea~ple nuclei~ ~cid wcul~ ~e prepared by a~y ~onvenient p~ocedure. The ~ucleic acid ~oul~ be aen~-tured to a 6ingle-~tranded ~ta~e by a~y co~ventio~al ~ean~. For example. DNA ~an be ~enatured by h~a~i~g it in an Appropriate buf er a~ 95C for 5 ~inu~e~.
Alternative~y, denatu~ation can b0 *ffected by t~e~ting DNA with 0.25 ~ NaOH ~or 10 oinu~es. I~ ~hi~ ~8~, following denatura~ion, ie i6 n~C~6~ary ~Q add a~
equivalent ~ount o~ ~cid (~.g. HCl) to neutr~liz~ ~he colution ~ontaininy the slngle-~trandea DNA. A~ ~hi~
point, ~t may al~o be neces~r~ eo ~d~u6t ehe ~o~ic str~ngth of the ~a~ple to opti~ize the binding a~
the DNA to a ~upport. It i~ ~vi~able to cool the denatur~d ~NA on ic~ to low~r tbe rate o~ renatur~tio~
o the ~ngl@-fitranded ~NA.
~he target nuclei~ acia can ~e i~o~ zed onto the ~ufa~e of a ~upport. Cl~si~ally, t~e &uppor~ o~ ~hoice ha~ bee~ ~ nitro~ellulo~e ~e~brane.
~f thi6 ~aterial 16 U~edD an ~l~guot of ta~get ~ucle~c acid ~an eith~r be 6potted onto ~he membrane o~ 810wly ~iltered through the me~brane con~ained in 9 d~vi~e ~ ~ \
lZ~

auch a6 a dot-blot or ~lot-blot ~an~rold~ Followi~g applicatlon of the target nuclelc acia to ~h~ ni~ro~
eellulo6e, the membrane i~ aried and hea~ad in ~
vacuulD oven at approximat~ly 00 for 0~5 - 2.0 ~ours S to a66ure 6eure ~ttachment to the nitroc~llulo~e.
The 6upport ~Daterial i~ rlot ne~es6ar~1y limited to nitrocellulo6e. Por example, charged nylon support6 sucA a6 Gene ~creenT" ~. I. du Pont de Nemour~ and Co~, Inc. O Wilmirlgton" I~E9 or Biotran6Tn 10 (ICN F~adiochemical6, Irv~ne, CA) can al~o be used.
The protocols de~relop~d by tbe manu~acturer~ of ~he membrane6 6hould be followea whe~ immobilizin~ nucl~ic ~c~d~ . T~i6 appl~ e~ whethsr ~h~ nu~leic ~ci~ ei~g af f ixed to the membra~e in ~ ~ot-blo~ æanifold or by 15 one oî the tran~f er protocol6 ~ ou~chern tran6~r ) commonly u6ed af ter electropho~e~c separation of ~he ~ample nucleic a~
In a different protocol, t~e ~a~et nuclei~
acid can be immobilizea by hybridizi~g it to a 6trarld 20 Of ~capture~' nucleic acid whicb i5 ~mobilized to a ~upport ~ate~ial. This capture nucleic ~cia ie ~om-plementary to a ~hort seguence o ba~ n t,h$~ targ~t nuclei~ acid arld 6p~ ically capture6 it ~rom a ~olu-tion ~chat ~nay conta~n substdntial quar.titi~ o~ o~he~
25 nucleic acid ~hic~h are of no i~nmeflia~ce inter~t.
The nu~leic aoia o~ intere~t, which ha~ been ~irmly ir~nobilized to ~ ~upport Dlateri~ a fiingle-~tranded or denatured state and i~ a~ailable for hyb~idiz~tion with an ANA prob~ ~ontair~
30 co~pler~entary sequ~n~* o ba~e~. The im~obili2ed targe~ nucleic a~ d and the ~upport ~ ne~ct ~e treated wit~ a buffer ~olutio~ con~n~g g~n~ri~
DNA (e.g., 60nicatea ~almon ~perm DN~) ~o eli~inate non6pecific binding ~itQæ ~or the 35 6pecific A~'IA probe. Typi~ally, thi6 ~er~eric DNA

~LZ~663 i6 pre6ent ~n the buffer at a concentrat~on of 10 ~g/ml ana 100 ~1 o~ this prehybridiza~ion buffe~ ~
required ~o~ each cm2 o 6upport ~aterial. Thi6 pre-hybr~dizat~on buffer can al~o contain 10% soaium 5 ~extran ~ulfate, 0.1% 60dium dodecyl ~ulfate, 50 ~ormamide, and SSPE, which i6 a ~ixture of ~odiu~
~hloride, soaiu~ pho~phate, ~nd ~DTA. In a~aition, the bu~fer can al60 ~ontain Denhardt'~ reagent, which i6 a mixture of ficoll, polyvinyl pyrollidone, and bovine 6eruD albumin.
Th~ 6upport to which the nuclei~ ~c~
imm~bilized i6 prehybri~ized ~n thi~ buffeE mixtu~ at an elevated temperature `(~.~., 37~ - 650C) rOr ~ period of time ranging grom ~everal ~3Ur~ to overni~ht in an effort to bloGk 6i~e8 on the immobilized ~ucleic acid to which the ~NA probe can be attachea non~peci~ically.
~ollowing prehyb~idization, ANA probe 1~ ad~ed to the prehybridiza~tion buffer to the ~e~ired final concentra~
tion, typically 10 - 100 ng/~L. Hybridization i6 hen carried out at t~e appaopriate elevated te~perature (e.~., 37 - 65~C) fo~ an appropriate pe~od o~ ti~e.
u6ually overn~yht.
Following hybridization, the support i~
: washed with ~ ~e~ie~ of bu~ers to ~emove ANh ~rob*
which ~a~ be non6pecif~cally attached to the ~upport.
Typically, a6 thifi ~equenee o~ wa6he6 progres~6. the concentration of the 6alt in the bu~fe~ iB reducea ~n~
the te~perature o the waB~ iB ~ncrea~ea. ~ollowing thi~ ~erie6 o~ wa~he~, the eu~por~ i~ then rin~ed wit~
the approprlato ~ufer eo re~ove any rea~ent~ fro~ ~he wa6h buffer~ that ~ay hsve a dçtri~ental etect on the activity o~ ~be ~ntibody-enzyme con~u~a~e ~o be ~ded later.

, 9fi~6~

D. Pcoduction of Antibodles Either polyclonal or monoclonal antibodie~
can be u6ed to detect arabinosç in ~he ANA pro~e mole~ules. Polyclonal antibodie6 can be produce~ by any convenient method u~ed to pr~duce antibo~i~6 to modified DNA te.g., S. Cohn and ~. W. Lieberman, J. ~iol. Chem. Volume 259~ 12456-6Z (1984)]. ~ike-wi6e, ~onoclonal antibodie~ can be produced by a~y o~
a number of pcocedure6 (H. G. Gratzner, Science Volume 218~ ~7~-5 ~1982)1.
I~ iR belieYed tha~ an arabinonucleo~de conjugated t~ a 6uitable carrier pro~ei~ . BSA~
can al60 6erve a~ the immunogen ~n antibody proauc-tion. However. t~ ~NA probe alone ~or hybridiz~a ~o ~omplementary ~uclei~ acid~ w~uld b@ preferr~d. Alter-~atively, the probe can be conjugated ~o a ~arri~r protein to 6~rYe a6 the ~mmunoge~. Okabaya6~i ~t ~1.
tcancer ~esearch ~olume 37, 619-62g (1977)1 repor~ed production of antibodie6 to l-fl-D-a abinofurano6yl~
cyto6ine (ara-C) in pla6ma. These antibodie6 ~id not cro66-react with deoxycyt~dine or ~y~idine ~hi~h ~iffer rom ara-C only in the 2~-po~itio~. ~his sugge6t6 ~ery 6trongly that a~tibodie6 o ~uit~ble 6pecificity ~or arabino6e i~ ~NA, whi~h wlll ~ot cro~-reac~ with deoxyribo6e in DNA or ribo~e i~ RN~, can ~edeveloped.

E. Pre~aration~ hg_Antibod~-Enzy~e Çon~uq~te Con~u~ation o the an~ibody to ~n enzym~ ca~
be carried ou~ by known ~ethod~. For ~xample, th~ u6e o~ glutaraltehyde to l~nk a~1no ~oup~ on the ~nzy~e and the antibody ~B a common appro~ch ~H. ~alli~, e~
al., Cancer Letter6 Volu~e 22, 163-170 (19~4)J. U~ing thi6 p~otocol, the Qnzy~e (e.g. peroxida6e) i~ ~llo~ed ~o react for 12 hour~ a~ roo~ ~empera~ure with gluear-~ ' lZ~

aldehyde. After remo~al o~ exce~0 glutar~ldehyde i~a gel ~iltration column. the actiYate~ ~zyme allowed to react with ~he antibody for 24 hours ~
4C. The antibody-enzym2 con3ugate ~B then purlfied 5 by dialy~i6, ammonium 6ulfate ~rec~pitat~o~, ~nd ~el f iltration chromatography. Con~ugation proce~ur~
u6ing ~leteroblfunct~onal ~ro661inkir~g agent~ ~uch a~
tho6e ae6cribed ~y J. W. Yr~ytag ~t ~1., Clin. Chem., Volu~e 30, ~17-420 (198~), 02 C. C. L~lar et ~
10 ~ . Che~.~ Volume 30, l8n9-l8ll ~1984) ca~ ~lxo be u~ed. I~ i6 ~xpected t~at perox~da~e. ~-galacto6i-da6e, gluco~e oxida6e, ~lkaline or aci~ ~ho6phata6e or any o~her u~e~ul enzy~e coul~ be so~3ugate~ to the ~ntibody (or ~ fragment ~bereof) and ~ub~equently u6ea to detect ~rabino6e ~n the ANA p obe.

P. Detection of ~ybr~d~ `
The hybri~ized ~ample would be incubat~a i~ a blocking buf~er whic~ con~ains reagen~6 to reduce ~on-~pecific ad60rption of the antibody-enzy~e conjugate to the membrane. Typically, ~ buff0r ~ontaining lt bovine ~eru~ albu~in i~ u~ed. Followin~ ~eat~Qnt with the blocking bu~fer, the membrane would be i~ubat~d with a~ appropria~0 antibody-~n2y~e ~o~uga~ ~or a 2~ period of ti~e su~h that the ~ntlbo~y ha6 ~n oppor-~unity to recognize a~d bind ~o ~ach arabi~o6e ~oi~ty in the stranD~ of probe ~ybrld~z~d to earget ~u~121c ~cid. ~he antibody-~nzy~e co~3u~a~e ~oul~ eon~t o~
an enzy~e coval~ntly linke~ ~o ~n ~n~lboay or ra~men~
thereo~ which ~ ~p~ciflc ~or arabinose in th~ probe.
Following bindin~ of ehe anei~oay-enzy~e con~ugat~ to the prob~. ~be ~embLan~ whi~h ~ow contaln~ con~ugate boun~ to ~h~ probe ~ybridl2e~ to the target nueleic aoid, i~ wa~hed ~gain ~i~h a 6erie~
of buffer6 ~o re~ove unbound and non6peci~ically bound .

:
6~

con~uqate f~om the ~upport. The appropriate enzyme 6ub6trate an~/or ~hromogen ~6 ln~uba~ed ~ith ~he product on the 6upport ~nd color development ~
allowed to proceed ~or a pre6crlbed perio~ of l;$me.
5 The extent oE hybridization could be ~u~nti~ea by mea6uring the rat~ of color ~evelopment or the total color developed a~ter a Bet time period.

Claims (3)

1. A probe for the detection of a preselected nucleic acid sequence comprising single stranded arabinonucleic acid consisting essentially of arabinonucleotides having 3' and 5' internucleotide linkages with a base linked at the 1' position, said base being selected from the group consisting essentially of adenine, guanine, cytosine, thymine, and uracil, said bases having a sequence complementary to said preselected nucleic acid sequence.
2. A method for identifying nucleic acid sequences comprising the steps of:
(a) rendering the target nucleic acids single-stranded;
(b) immobilizing the single-stranded nucleic acids onto a support;
(c) allowing said single-stranded nucleic acids to hybridize with a single-stranded arabinonucleic acid probe, said arabinonucleic acid consisting essentially of arabinonucleotides having 3' and 5' internucleotide linkages with a base linked at the 1' position, said base being selected from the group consisting essentially of adenine, guanine, cytosine, thymine, and uracil;
(d) washing said support to remove arabinonucleic acid not incorporated into the hybrid formed on the support; and (e) determining the presence of arabinonucleic acid in the hybrid formed on the support by contacting it with an anti-arabinose antibody-label conjugate and detecting said label.
3. The method of Claim 2 wherein the label is an enzyme.
CA000525772A 1985-12-23 1986-12-18 Arabinonucleic acid probes for dna/rna assays Expired - Lifetime CA1296663C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US812,574 1985-12-23
US06/812,574 US4760017A (en) 1985-12-23 1985-12-23 Arabinonucleic acid probes for DNA/RNA assays

Publications (1)

Publication Number Publication Date
CA1296663C true CA1296663C (en) 1992-03-03

Family

ID=25210011

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000525772A Expired - Lifetime CA1296663C (en) 1985-12-23 1986-12-18 Arabinonucleic acid probes for dna/rna assays

Country Status (5)

Country Link
US (2) US4760017A (en)
EP (1) EP0227459B1 (en)
JP (1) JPS62158299A (en)
CA (1) CA1296663C (en)
DE (1) DE3688931T2 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760017A (en) * 1985-12-23 1988-07-26 E. I. Du Pont De Nemours And Company Arabinonucleic acid probes for DNA/RNA assays
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US5082830A (en) * 1988-02-26 1992-01-21 Enzo Biochem, Inc. End labeled nucleotide probe
US5824796A (en) * 1988-09-28 1998-10-20 Epoch Pharmaceuticals, Inc. Cross-linking oligonucleotides
USRE38416E1 (en) 1988-09-28 2004-02-03 Epoch Biosciences, Inc. Cross-linking oligonucleotides
US5849482A (en) * 1988-09-28 1998-12-15 Epoch Pharmaceuticals, Inc. Crosslinking oligonucleotides
US6005087A (en) * 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
US6395492B1 (en) * 1990-01-11 2002-05-28 Isis Pharmaceuticals, Inc. Derivatized oligonucleotides having improved uptake and other properties
US5852182A (en) * 1990-01-11 1998-12-22 Isis Pharmaceuticals Inc. Thiol-derivatized oligonucleosides
DE69133405T2 (en) * 1990-01-11 2005-07-07 Isis Pharmaceutical, Inc., Carlsbad Oligonucleotide derivatives for detecting and modulating RNA activity and gene expression
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US6399754B1 (en) * 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US6114513A (en) * 1990-01-11 2000-09-05 Isis Pharmaceuticals, Inc. Thiol-derivatized oligonucleotides
US6339066B1 (en) 1990-01-11 2002-01-15 Isis Pharmaceuticals, Inc. Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C
US6013431A (en) * 1990-02-16 2000-01-11 Molecular Tool, Inc. Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators
US6262241B1 (en) * 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
US5177196A (en) * 1990-08-16 1993-01-05 Microprobe Corporation Oligo (α-arabinofuranosyl nucleotides) and α-arabinofuranosyl precursors thereof
US5185264A (en) * 1990-11-09 1993-02-09 Abbott Laboratories Diluent buffer and method for diluting an assay component
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US6136601A (en) * 1991-08-21 2000-10-24 Epoch Pharmaceuticals, Inc. Targeted mutagenesis in living cells using modified oligonucleotides
US6537973B1 (en) 1992-03-16 2003-03-25 Isis Pharmaceuticals, Inc. Oligonucleotide inhibition of protein kinase C
AU2320597A (en) 1996-03-19 1997-10-10 Molecular Tool, Inc. Method for determining the nucleotide sequence of a polynucleotide
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
GB9624165D0 (en) * 1996-11-19 1997-01-08 Amdex A S Use of nucleic acids bound to carrier macromolecules
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
AU2001276691A1 (en) * 2000-08-03 2002-02-18 Matsushita Electric Industrial Co., Ltd. Brushless motor and method of manufacturing the brushless motor
AU2003273336A1 (en) * 2002-09-18 2004-04-08 Isis Pharmaceuticals, Inc. Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
CA2504929C (en) 2002-11-05 2014-07-22 Charles Allerson Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
CA2569419A1 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US20060040258A1 (en) * 2004-08-23 2006-02-23 Huiyan Guo Water-soluble conjugates and methods of preparation
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US20060205090A1 (en) * 2005-03-14 2006-09-14 Newton Michael W Water-soluble conjugates for electrochemical detection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093714A (en) * 1974-03-15 1978-06-06 Icn Pharmaceuticals, Inc. 9β-D-Arabinofuranosylpurine nucleotides and method of use
JPS58221168A (en) * 1982-06-17 1983-12-22 Yamasa Shoyu Co Ltd Quantitative determination of arabinonucleoside
US4556643A (en) * 1982-07-26 1985-12-03 Agracetus Assay method and probe for polynucleotide sequences
EP0144913A3 (en) * 1983-12-12 1986-08-20 Miles Inc. Hybridization assay employing labeled probe and anti-hybrid
US4724202A (en) * 1983-12-12 1988-02-09 Molecular Diagnostics, Inc. Use of non-hybridizable nucleic acids for the detection of nucleic acid hybridization
US4883750A (en) * 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
JPS62128807A (en) * 1985-11-30 1987-06-11 Sumitomo Rubber Ind Ltd Builtup body of run-flat tire for atv and rim
US4760017A (en) * 1985-12-23 1988-07-26 E. I. Du Pont De Nemours And Company Arabinonucleic acid probes for DNA/RNA assays
JP2633832B2 (en) * 1986-05-16 1997-07-23 住友ゴム工業 株式会社 Wheel rim and tire assembly

Also Published As

Publication number Publication date
JPS62158299A (en) 1987-07-14
EP0227459A2 (en) 1987-07-01
DE3688931T2 (en) 1993-12-23
US5077196A (en) 1991-12-31
US4760017A (en) 1988-07-26
JPH0529439B2 (en) 1993-04-30
EP0227459B1 (en) 1993-08-25
DE3688931D1 (en) 1993-09-30
EP0227459A3 (en) 1989-01-25

Similar Documents

Publication Publication Date Title
CA1296663C (en) Arabinonucleic acid probes for dna/rna assays
EP0203959B1 (en) Nucleotide analogs for nucleic acid labeling and detection
US7034133B2 (en) Oligonucleotide analogues
US7572582B2 (en) Oligonucleotide analogues
JP2955759B2 (en) Methods for amplifying and detecting nucleic acid sequences
JP4452445B2 (en) Mobility-modified nucleobase polymers and methods of using the same
ES2322215T3 (en) MARKING PROCEDURE OF A RIBONUCLEIC ACID.
EP0231495B1 (en) One-step method and polynucleotide compounds for hybridizing to target polynucleotides
CA2303299A1 (en) Oligonucleotide analogues
JPH06508022A (en) Biomolecule-specific aptamers and production methods
KR20020007332A (en) One step sample preparation and detection of nucleic acids in complex biological samples
JPH11509528A (en) Crosslinkable oligonucleotide
JPH02503146A (en) Non-nucleotide ligation reagent for nucleotide probes
JPH01500461A (en) Nucleic acid probe assay methods and compositions
IL111733A (en) Nucleic acid analogs with a chelating functionality
AU1156897A (en) Methods and compositions for detection of specific nucleotide sequences
WO1998011120A1 (en) A method of nucleic acid sequencing
JPH06509945A (en) Crosslinkable oligonucleotides for enzyme-mediated triplex formation
WO1989002896A1 (en) Acridinium ester labelling and purification of nucleotide probes
US6143879A (en) Nucleotide cleaving agents and method
JPH01317400A (en) Nucleic acid probe containing terminal nucleotide chemically modified at 5'(oh) positon for purpose of non-radioactive labelling
WO2019104070A1 (en) O-nitrobenzyl photocleavable bifunctional linker
CN112400026A (en) Compositions and methods for affinity directed enrichment of rare species
JPH02502284A (en) Non-nucleotide reagent for oligonucleotide terminal substitution
JPH05292971A (en) Production of biotinized cdna library and substraction using the same

Legal Events

Date Code Title Description
MKLA Lapsed